Under 21 CFR 56.113 and 45 CFR 46.113, an IRB shall have the authority to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated with unexpected serious harm to subjects. The conditions under which approval of previously approved research may be suspended or terminated, and the procedures to be followed for suspending or terminating research are described.